Eur Respir J 2000; 16: 397-403
Copyright © ERS Journals Ltd 2000
Interaction of vitamin C with the relation between smoking and obstructive airways disease in EPIC Norfolk. European Prospective Investigation into Cancer and Nutrition
LA Sargeant,
A Jaeckel,
and
NJ Wareham
Previous studies have reported an association between plasma vitamin C levels and respiratory function, but have not examined the role of vitamin C as an effect modifier of the relation between cigarette smoking and obstructive airways disease (OAD). This question was investigated in a cross-sectional analysis of a population-based study of 3,714 males and 4,256 females aged 45-74 yrs. Undiagnosed OAD was defined as a forced expiratory volume in one second (FEV1) of <80% of the predicted value and FEV1/forced vital capacity of <70% without self-reported OAD. An increase of 20 micromol x L(-1) (or 1 SD) in plasma vitamin C concentration was associated with a 13% reduction in the risk of having OAD (adjusted odds ratio (OR) (95% confidence interval) 0.87 (0.77-0.98)). The OR for current smokers relative to never smokers within the lowest quintile of plasma vitamin C concentration was 5.93 (3.03-11.61). The risk in the upper four quintiles was 2.84 (1.92-4.19). Within the lowest quintile of plasma vitamin C concentration, the risk in former smokers was strongly related to the time since quitting (interaction significant, p=0.001). These findings support a protective role for vitamin C against the risk of obstructive airways disease and support the hypothesis that vitamin C may be an effect modifier for the adverse effects of smoking on the risk of obstructive airways disease.
This article has been cited by other articles:

|
 |

|
 |
 
I. Rahman
Review: Antioxidant therapeutic advances in COPD
Therapeutic Advances in Respiratory Disease,
December 1, 2008;
2(6):
351 - 374.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Proskocil, H. S. Sekhon, J. A. Clark, S. L. Lupo, Y. Jia, W. M. Hull, J. A. Whitsett, B. C. Starcher, and E. R. Spindel
Vitamin C Prevents the Effects of Prenatal Nicotine on Pulmonary Function in Newborn Monkeys
Am. J. Respir. Crit. Care Med.,
May 1, 2005;
171(9):
1032 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. McKeever, S. Scrivener, E. Broadfield, Z. Jones, J. Britton, and S. A. Lewis
Prospective Study of Diet and Decline in Lung Function in a General Population
Am. J. Respir. Crit. Care Med.,
May 1, 2002;
165(9):
1299 - 1303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. CROXTON, G. G. WEINMANN, R. M. SENIOR, and J. R. HOIDAL
Future Research Directions in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
March 15, 2002;
165(6):
838 - 844.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. McCLOSKEY, B. D. PATEL, S. J. HINCHLIFFE, E. D. REID, N. J. WAREHAM, and D. A. LOMAS
Siblings of Patients With Severe Chronic Obstructive Pulmonary Disease Have a Significant Risk of Airflow Obstruction
Am. J. Respir. Crit. Care Med.,
October 15, 2001;
164(8):
1419 - 1424.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the European Respiratory Society.
|